Trials / Conditions / Relapsed or Refractory Follicular Lymphoma
Relapsed or Refractory Follicular Lymphoma
3 registered clinical trials studyying Relapsed or Refractory Follicular Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma NCT07343934 | University of Pennsylvania | Phase 1 |
| Withdrawn | A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed o NCT06313996 | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | Phase 3 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to NCT04712097 | Hoffmann-La Roche | Phase 3 |